A Case of Resistance to Selective RET-TKI Therapy With Pleural-Genotyped MET Amplification and Response to Crizotinib

被引：1
|
作者：
Chen, Kaiyan [1 ,2 ,3 ]
Zhang, Fanrong [1 ,4 ]
Pan, Guoqiang [1 ,2 ,3 ,5 ]
Sheng, Jiamin [1 ,2 ,3 ,5 ]
Ye, Junyi [6 ]
Xu, Yanjun [1 ,2 ,3 ]
Yu, Xiaoqing [1 ,2 ,3 ]
Huang, Zhiyu [1 ,2 ,3 ]
Fan, Yun [1 ,2 ,3 ]
机构：
[1] Univ Chinese Acad Sci, Canc Hosp, Zhejiang Canc Hosp, Hangzhou, Peoples R China
[2] Chinese Acad Sci, Inst Canc & Basic Med, Hangzhou, Peoples R China
[3] Zhejiang Canc Hosp, Dept Thorac Med Oncol, Hangzhou, Peoples R China
[4] Zhejiang Canc Hosp, Dept Breast Surg, Hangzhou, Peoples R China
[5] Wenzhou Med Univ, Clin Med Coll 1, Dept Oncol, Wenzhou, Peoples R China
[6] Bioinformat Dept, Burning Rock Biotech, Guangzhou, Peoples R China
来源：
CLINICAL LUNG CANCER | 2021年 / 22卷 / 01期
关键词：
Crizotinib; MET; Non-small-cell lung cancer; RET; Resistance; CELL LUNG-CANCER; ACQUIRED-RESISTANCE; OPEN-LABEL; CARCINOMAS; PHASE-2;
D O I：
10.1016/j.cllc.2020.07.007
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：E1 / E4
页数：4
相关论文
共 32 条
  • [21] Treatment Response to Immunotherapy After Crizotinib Resistance in a Patient With Pulmonary Sarcomatoid Carcinoma Harboring MET Exon 14 Skipping Mutation: A Case Report
    Gu, Ling
    Wei, Xiaoying
    Zhang, Zixiang
    Heng, Wei
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2022, 16
  • [22] Treatment Response to Immunotherapy After Crizotinib Resistance in a Patient With Pulmonary Sarcomatoid Carcinoma Harboring MET Exon 14 Skipping Mutation: A Case Report
    Gu, Ling
    Wei, Xiaoying
    Zhang, Zixiang
    Heng, Wei
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2022, 16
  • [23] STRN-ALK Fusion in a Case of Malignant Peritoneal Mesothelioma: Mixed Response to Crizotinib, Mode of Resistance, and Brigatinib Sequential Therapy
    Gerthofer, Valeria
    Scheiter, Alexander
    Lueke, Florian
    Keil, Felix
    Utpatel, Kirsten
    Poehmerer, Laura-Maria-Giovanna
    Seitz, Johannes
    Niessen, Christoph
    Ignatov, Atanas
    Dietmaier, Wolfgang
    Calvisi, Diego F.
    Evert, Matthias
    Ortmann, Olaf
    Seitz, Stephan
    JCO PRECISION ONCOLOGY, 2021, 5 : 1507 - 1513
  • [24] Crizotinib rechallenge reverses MET amplification-mediated resistance to ALK inhibitors in a patient with advanced ALK-rearranged non-small cell lung cancer: a case report
    Wang, Rixiang
    Chen, Weizhuang
    Jiao, Wenrui
    Ren, Feng
    Wu, Hongcheng
    Wu, Shibo
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2020, 13 (08): : 6163 - 6167
  • [25] A Case Report of Primary Resistance to EGFR TKI in Lung Adenocarcinoma Due to Coexisting MET Exon 14 Skipping Mutation with Excellent Response to Combination of Gefitinib and Capmatinib
    Raut, Nirmal Vivek
    Srivastava, Siddharth
    Gangwani, Guarav Dilip
    Ali, Heena Sajid
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2021, 42 (02) : 204 - 207
  • [26] Case Report: A novel MET exon 14 skipping mutation after EGFR-TKI resistance in advanced lung adenocarcinoma and sustained clinical response to savolitinib
    Xue, Yinyin
    Li, Wen
    Li, Pengfei
    Huang, Kaili
    Zhou, Qinghua
    Wu, Qiang
    FRONTIERS IN PHARMACOLOGY, 2025, 16
  • [27] Rapid response of brain metastasis to crizotinib in a patient with KLC1-ALK fusion and MET gene amplification positive non-small cell lung cancer:a case report
    Peng Wang
    Pei Xiao
    Yingnan Ye
    Pengpeng Liu
    Lei Han
    Li Dong
    Chunhua She
    Jinpu Yu
    Cancer Biology & Medicine, 2017, 14 (02) : 183 - 186
  • [28] Rapid response of brain metastasis to crizotinib in a patient with KLC1-ALK fusion and MET gene amplification positive non-small cell lung cancer:a case report
    Peng Wang
    Pei Xiao
    Yingnan Ye
    Pengpeng Liu
    Lei Han
    Li Dong
    Chunhua She
    Jinpu Yu
    Cancer Biology & Medicine, 2017, (02) : 183 - 186
  • [29] Rapid response of brain metastasis to crizotinib in a patient with KLC1-ALK fusion and MET gene amplification positive non-small cell lung cancer: a case report
    Wang, Peng
    Xiao, Pei
    Ye, Yingnan
    Liu, Pengpeng
    Han, Lei
    Dong, Li
    She, Chunhua
    Yu, Jinpu
    CANCER BIOLOGY & MEDICINE, 2017, 14 (02) : 183 - 186
  • [30] Durable complete response after afatinib and crizotinib in an advanced non-small cell lung cancer patient with EGFR L861Q mutation and acquired MET amplification: a case report
    Long, Yaling
    Zhang, Kai
    Li, Yanying
    Yu, Min
    Zhu, Jiao
    Huang, Meijuan
    ANNALS OF PALLIATIVE MEDICINE, 2020, 9 (05) : 3609 - 3613
1234